Jeffrey Alan Wolf - 23 Dec 2021 Form 4 Insider Report for Synthetic Biologics, Inc. (TOVX)

Role
Director
Signature
/s/ Jeffrey Alan Wolf
Issuer symbol
TOVX
Transactions as of
23 Dec 2021
Net transactions value
$0
Form type
4
Filing time
27 Dec 2021, 16:09:23 UTC
Previous filing
15 Dec 2021
Next filing
03 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TOVX Stock Options (right to buy) Award $0 +200,000 $0.000000 200,000 23 Dec 2021 Common Stock 200,000 $0.3314 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest pro rata on a monthly basis over 12 months.